Patient-Reported Outcomes by Baseline Body Surface Area Involvement Among Individuals Initiating Biologic Therapy: Results from the CorEvitas Psoriasis Registry

Abstract Introduction Psoriasis body surface area (BSA) of 10% or more has been a major criterion for determining systemic therapy eligibility. However, patients with BSA < 10% and even ≤ 3% may have high disease burden and difficulties accessing biologics. To assess psoriasis burden among patients...

Celý popis

Podrobná bibliografie

Hlavní autoři:	April W. Armstrong, Steven R. Feldman, Timothy Fitzgerald, Theodore Alkousakis, Adam Sima, Alvin Li, Hyung-Joo Kang, Sandra I. Main, Saakshi Khattri, Linda Stein Gold
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Adis, Springer Healthcare 2025-06-01
Edice:	Dermatology and Therapy
Témata:	Biologics Body surface area Patient-reported outcomes Psoriasis
On-line přístup:	https://doi.org/10.1007/s13555-025-01456-5
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!